Short answer: yes. Ozempic is a brand name for semaglutide. This guide explains the difference between the brand name and the research compound, how Wegovy fits in, and what to know about sourcing semaglutide for research.
Semaglutide, Ozempic, and Wegovy are all the same molecule. Ozempic and Wegovy are brand names manufactured by Novo Nordisk — Ozempic is approved for type 2 diabetes, Wegovy for chronic weight management. Research-grade semaglutide is the same active compound, available for research purposes from suppliers like Purgo Labs.
Ozempic and Wegovy are the same molecule (semaglutide) — Ozempic is dosed at 0.5–2mg/week for T2D; Wegovy at 2.4mg/week for obesity. Same GLP-1R mechanism, different approved indications.

One row per compound: the amount and schedule administered in a specific indexed study, who received it, and the paper. These are reports of what was done in that study, not recommendations, and several are animal or single-dose studies. Where no indexed human regimen exists we say so rather than print a number. Community "stacks" and cycle schedules are not reproduced on this site.
Research use only. Compound Review scores vendors on documentation — laboratory certificates, lot records, pricing and company identity. Nothing on this page is guidance on human or veterinary use, dosing or health outcomes.
| Compound | Regimen in the study | Population | Source |
|---|---|---|---|
| Semaglutide | 2.4 mg subcutaneous once weekly for 68 weeks (after dose escalation), plus lifestyle intervention | 1,961 adults with BMI ≥30 (or ≥27 with a weight-related condition), no diabetes — STEP 1 | PMID 33567185 Wilding et al., N Engl J Med 2021 |
Research use only. Compound Review scores vendors on documentation — laboratory certificates, lot records, pricing and company identity. Nothing on this page is guidance on human or veterinary use, dosing or health outcomes.
| Feature | Ozempic | Wegovy | Research Semaglutide |
|---|---|---|---|
| Active molecule | Semaglutide | Semaglutide | Semaglutide |
| Manufacturer | Novo Nordisk | Novo Nordisk | Various (e.g. Purgo Labs) |
| FDA approval | Type 2 diabetes | Chronic weight mgmt | Not approved (research only) |
| Max dose | 2 mg/week | 2.4 mg/week | Researcher-determined |
| Delivery format | Pre-filled pen | Pre-filled pen | Lyophilized powder + BAC water |
| Requires prescription | Yes | Yes | No (research use) |
| Cost (approx.) | $900+/month | $1,300+/month | Significantly lower |
| Third-party COA | FDA-regulated QC | FDA-regulated QC | Supplier-dependent (Purgo: yes) |
Pharmaceutical companies brand the same active ingredient under different names for different indications. This is common practice — the same molecule can be approved for multiple conditions under different brand names, each with its own clinical trial program, dosing regimen, and marketing approval.
Semaglutide was first developed as Ozempic for type 2 diabetes management. Novo Nordisk then ran separate clinical trials (the STEP program) at a higher dose (2.4 mg/week vs 2 mg/week) specifically for weight management, which resulted in the Wegovy approval. The molecule is identical — only the dose and approved indication differ.
Research-grade semaglutide is the same molecule without the brand premium. It is sold as a lyophilized powder that researchers reconstitute with bacteriostatic water, rather than in a pre-filled pen. The active compound is chemically identical.
A Certificate of Analysis from an independent lab confirming purity (≥98%) and absence of contaminants. This is non-negotiable for research quality.
High-performance liquid chromatography confirms the compound's identity and purity. Look for suppliers who publish HPLC data, not just purity claims.
Vial weight should match labeled weight. Underdosing is common with low-quality suppliers. Purgo Labs uses verified weights.
Lyophilized semaglutide should be stored at 2–8°C. Suppliers who ship without cold packs compromise compound integrity.
Research-grade semaglutide contains the same active molecule as Ozempic. Efficacy depends on purity and accurate dosing. Reputable suppliers like Purgo Labs provide third-party COAs confirming purity. The key difference is that Ozempic is FDA-approved for human use, while research semaglutide is sold for research purposes only.
Ozempic's price includes FDA approval costs, clinical trials, manufacturing in pre-filled pens, pharmacy distribution, and Novo Nordisk's patent premium. Research-grade semaglutide bypasses these costs. The active molecule is the same, but the regulatory pathway and delivery format differ.
FDA-approved Ozempic and Wegovy require a prescription. Research-grade semaglutide is available from research chemical suppliers like Purgo Labs for research purposes only. It is not sold for human consumption and is not a substitute for prescription medication.
Purgo Labs provides research-grade semaglutide with third-party COAs and HPLC verification. Code HEALTH is 20% off every order at Purgo Labs (verified recurring).
Buy Semaglutide at Purgo Labs